Company / Book Value per Share
ResMed Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$40.625
FY2025
5-year range
$19.917 / $40.625
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
#36 of 163
Health Care
What the data says
ResMed's book value per share of $40.625 is higher than 78% of companies in the Health Care sector (FY2025). Book Value per Share has increased for 9 consecutive years, from $12.065 in FY2016 to $40.625 in FY2025.
Based on SEC 10-K filings.
$40.625 in FY2025 with a 5-year CAGR of +18.5%. Top quartile in the Health Care sector.
Improved from $28.208 to $40.625 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +20.8%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Sector benchmark
-14.3% below sector average
Key checks
Key Insights
- ResMed's book value per share has grown for 9 consecutive years.
- 5-year CAGR of +18.5%, indicating consistent growth.
- In FY2025, book value per share increased 22.8% year-over-year.
- Ranks #36 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.625 | +22.8% |
| FY2024 | $33.074 | +17.3% |
| FY2023 | $28.208 | +22.2% |
| FY2022 | $23.074 | +15.9% |
| FY2021 | $19.917 | +14.6% |
| FY2020 | $17.382 | +19.7% |
| FY2019 | $14.523 | +0.3% |
| FY2018 | $14.482 | +3.9% |
| FY2017 | $13.936 | +15.5% |
| FY2016 | $12.065 | +6.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026